First Circ. Revives Boston Scientific Securities Suit

Law360, New York (April 18, 2008, 12:00 AM EDT) -- A case filed by Boston Scientific Corp. shareholders over the biotech company's alleged failure to disclose information about the recall of one of its stents will stay alive, now that an appeals court has found that the plaintiffs met the federal pleading standards for fraud.

In a ruling handed down on April 16, a three-judge panel of the U.S. Court of Appeals for the First Circuit overturned a lower court ruling that granted Boston Scientific's motion to dismiss the class action filed over misstatements relating to...
To view the full article, register now.